{"id":"W4206112747","doi":"10.1007/s13555-021-00679-6","title":"Efficacy of Risankizumab versus Secukinumab in Patients with Moderate-to-Severe Psoriasis: Subgroup Analysis from the IMMerge Study","year":2022,"lang":"en","type":"article","venue":"Dermatology and Therapy","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":26,"is_retracted":false,"has_abstract":true,"ca_institutions":"Dalhousie University; Queen Elizabeth II Health Sciences Centre","funders":"Celgene; Eli Lilly and Company; AbbVie; Bristol-Myers Squibb; Amgen","keywords":"Medicine; Psoriasis Area and Severity Index; Secukinumab; Internal medicine; Body mass index; Psoriasis; Disease; Dermatology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001247778,0.0002234114,0.0005477542,0.0002056189,0.0003639394,0.000007799143,0.0002678294,0.0001042626,0.0004359059],"category_scores_gemma":[0.000008826692,0.000151176,0.00009618457,0.000637217,0.00008819567,0.00004600537,0.00009664868,0.0002087717,0.00001218081],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0000263878,"about_ca_system_score_gemma":0.0000315368,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000680082,"about_ca_topic_score_gemma":0.000437958,"domain_scores_codex":[0.9981612,0.0007969156,0.0003076362,0.0003898159,0.00007101968,0.0002734395],"domain_scores_gemma":[0.9990146,0.0004026257,0.0001358595,0.0003941461,0.00003271337,0.00002009479],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.03866224,0.001844177,0.9370677,0.000001317842,0.006077559,0.00002006079,0.006296755,0.0001720545,0.00007208074,0.00008355878,0.0001170341,0.009585401],"study_design_scores_gemma":[0.03825581,0.0009593727,0.9569266,0.000002502285,0.0006136087,0.000005239763,0.00171938,0.000006763326,0.0005038564,0.00004053147,0.0007696163,0.0001967352],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9959916,0.00265326,0.000008184248,0.0001293902,0.0003488495,0.0006397978,0.0001588115,0.0000209306,0.00004913994],"genre_scores_gemma":[0.9992427,0.00008281694,0.00001216764,0.0001312099,0.00000782888,0.0001632071,0.0003246524,0.00001446479,0.00002101104],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01985882,"threshold_uncertainty_score":0.6164777,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01272238365555321,"score_gpt":0.2317351978191852,"score_spread":0.2190128141636319,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}